A Clinical Case Study From Rathna Siddha Hospital & Herbal Research Centre

Dr. Pazhaniyappan, BSMS
Published by Rathna Siddha Hospital & Herbal Research Centre

Key Takeaways

Severe chemotherapy complications often affect multiple physiological systems beyond the primary cancer itself, including digestion, immunity, respiration, sleep, circulation, and inflammatory regulation.
In Siddha medicine, post-oncology systemic exhaustion is frequently interpreted as a major derangement of Vatham and Pitham associated with weakened digestive metabolism and toxic inflammatory accumulation.
A 44-year-old female breast cancer patient with severe post-chemotherapy respiratory distress, leukocyte fluctuation, vomiting, constipation, and inflammatory burden demonstrated meaningful symptomatic stabilization through individualized Siddha supportive care.
Serial investigations revealed temporary improvement in tumor markers and stabilization of white blood cell levels, while clinical observations showed marked reduction in vomiting, improvement in bowel regularity, relief from abdominal bloating, and restoration of respiratory comfort.
The patient progressed from profound post-chemotherapy systemic instability toward improved functional tolerance, digestive regulation, and daily physiological stability before discharge.

Why Post-Chemotherapy Recovery Often Becomes More Than Cancer Treatment

Modern oncology has significantly improved survival outcomes in breast cancer management through surgery, chemotherapy, radiotherapy, and targeted therapeutic interventions. However, many patients continue to suffer from prolonged systemic complications even after acute cancer treatment has been completed.

Persistent vomiting, inflammatory stress, digestive dysfunction, respiratory compromise, disturbed sleep, marrow suppression, weakness, anorexia, constipation, and metabolic exhaustion frequently delay meaningful recovery and severely reduce quality of life.

From the Siddha perspective, cancer-related physiological exhaustion is not viewed as an isolated organ disorder. Instead, it is interpreted as a deep systemic imbalance affecting digestion, circulation, tissue nourishment, inflammatory regulation, and internal adaptive intelligence.

This clinical case from Rathna Siddha Hospital & Herbal Research Centre demonstrates how prognosis-oriented Siddha supportive management was utilized to stabilize severe post-chemotherapy complications in a patient recovering from carcinoma breast treatment.

Clinical Presentation: When Chemotherapy Triggered Systemic Collapse

Mrs. Indhumathi, a 44-year-old female from Tiruchirappalli, was diagnosed with carcinoma breast involving the left breast in 2022.

Following diagnosis, she underwent:

Left mastectomy in November 2025
Intensive chemotherapy on December 20, 2025

Within twenty-four hours of chemotherapy administration, the patient developed severe systemic complications including:

Critically low white blood cell count
High fever
Severe chest congestion
Persistent cough
Respiratory distress
Profound generalized weakness

The severity of the condition required immediate Intensive Care Unit stabilization.

Even after emergency management, the patient continued to experience:

Persistent vomiting tendency
Severe epigastric burning
Constipation
Abdominal bloating
Disturbed sleep
Severe rib and back pain
Loss of appetite
Respiratory discomfort
Extreme fatigue
Delayed healing changes around the postoperative axillary region

On December 31, 2025, she was admitted to Rathna Siddha Hospital & Herbal Research Centre for prolonged Siddha supportive management.

Understanding the “Vatha–Pitha Exhaustion State” After Chemotherapy

In Siddha medicine, aggressive chemotherapy and chronic inflammatory disease are believed to provoke severe derangement of Vatham and Pitham, the physiological principles governing movement, digestion, circulation, heat regulation, metabolism, and systemic coordination.

When these biological forces become disturbed, patients may continue experiencing instability even after primary cancer treatment is completed.

In this patient, Siddha evaluation identified several interconnected patterns.

The first was digestive collapse. Persistent vomiting, abdominal bloating, constipation, anorexia, and epigastric burning were interpreted as manifestations of severely disturbed digestive metabolism and internal inflammatory heat.

The second was inflammatory overload. Elevated CRP, Ferritin, D-Dimer, and tumor markers reflected a prolonged systemic inflammatory state associated with ongoing physiological stress.

The third was tissue depletion and physiological exhaustion. Persistent weakness, disturbed sleep, reduced tolerance, respiratory discomfort, and fluctuating pain patterns suggested weakened systemic adaptability following chemotherapy-induced metabolic strain.

This inflammatory burden was strongly reflected in laboratory findings.

Investigation	Initial Phase	Improvement Phase	Late Observation	Clinical Interpretation
CA-125 (U/mL)	355.0	47.4	181.4	Initial stabilization followed by inflammatory flare
CA 15-3 (U/mL)	687.0	43.6	916.0	Progressive tumor-associated activity
WBC (/μL)	12,950	4,660	6,190	Gradual immunological stabilization
CRP (mg/L)	Elevated	Partial reduction	83	Persistent inflammatory activation
Ferritin (ng/mL)	846	—	1,358	Ongoing inflammatory burden
D-Dimer (ng/mL)	Elevated	Partial stabilization	5,686	Severe inflammatory and thrombotic stress

These findings suggested that the patient remained in a prolonged state of systemic physiological stress even after completion of acute oncology treatment.

Why Siddha Supportive Care Focused on Whole-Body Stabilization

Rather than concentrating only on isolated symptoms, the Siddha approach aimed to restore coordination between digestion, circulation, respiration, bowel movement, sleep regulation, inflammatory balance, and tissue nourishment.

According to Siddha principles, physiological recovery improves when the body’s internal adaptive intelligence begins functioning harmoniously again.

The treatment protocol at Rathna Siddha Hospital & Herbal Research Centre therefore progressed through multiple supportive phases.

Phase I: Digestive and Metabolic Stabilization

One of the most significant clinical concerns was severe digestive dysfunction.

The patient experienced:

Recurrent vomiting
Epigastric burning
Severe constipation
Abdominal bloating
Marked appetite suppression

In Siddha medicine, digestive impairment is considered a major barrier to recovery because tissue nourishment cannot occur effectively when metabolic transformation becomes disturbed.

The patient was therefore administered individualized supportive formulations including:

Cesalene Render syrup
Laadla drops
Medicated ghee-based therapies

These medicines were selected to:

Reduce inflammatory gastric irritation
Improve digestive adaptability
Normalize bowel movement
Reduce abdominal bloating
Improve appetite and systemic tolerance

As digestive regulation gradually improved, the patient began demonstrating:

Reduced vomiting frequency
Better bowel evacuation
Improved sleep tolerance
Reduced abdominal discomfort
Greater physical stability

Phase II: Internal Siddha Supportive Therapy

The next therapeutic phase focused on reducing systemic exhaustion and supporting physiological resilience.

Specialized Siddha formulations including:

Meme Homo Mithiyer tablets
Kodi Nelind preparations
Abroria Japan formulations
Grape Seed extracts

were administered to:

Reduce oxidative stress
Support cellular resilience
Improve tissue adaptability
Enhance systemic strength
Moderate inflammatory burden

In Siddha supportive oncology care, such formulations are traditionally utilized to improve the body’s adaptive tolerance during prolonged inflammatory illness and post-chemotherapy exhaustion.

Phase III: Pain Regulation and Bowel Restoration

Persistent rib pain radiating toward the back remained a major complaint throughout observation.

The patient also experienced prolonged constipation associated with abdominal pressure and sleep disturbance.

Siddha therapies including:

Vine Wormis
Farcomy tablets

were utilized to:

Improve bowel evacuation
Reduce abdominal stagnation
Moderate pain intensity
Improve functional comfort
Reduce Vatha aggravation

One of the most clinically important observations was that improvement in bowel regularity closely paralleled improvement in sleep quality, respiratory comfort, and overall systemic tolerance.

Phase IV: Prognosis-Oriented Daily Monitoring

A defining feature of management at Rathna Siddha Hospital & Herbal Research Centre was continuous prognosis-based observation rather than fixed symptomatic treatment.

Daily monitoring included:

Vomiting frequency
Bowel movement quality
Sleep rhythm
Appetite variation
Respiratory tolerance
Pain fluctuation
Functional mobility
Systemic strength

This allowed therapies to be dynamically modified according to changing physiological response patterns rather than relying upon static prescription schedules.

What the Recovery Data Revealed

One of the most important observations in this case was the gradual stabilization of gastrointestinal and respiratory symptoms during the final treatment phase.

Persistent vomiting episodes progressively reduced before stopping completely between April 18 and April 19, 2026. Simultaneously, bowel movement normalized and abdominal bloating reduced significantly.

Vital monitoring also demonstrated improvement in respiratory stability despite fluctuating inflammatory burden.

Date	Clinical Phase	Blood Pressure	Pulse	SpO₂	Clinical Observation
31/12/2025	Admission	93/68	105	94%	Post-ICU systemic stress
13/01/2026	Early Recovery	89/60	90	99%	Improved oxygenation
19/02/2026	Mid Recovery	115/85	114	99%	Hemodynamic stabilization
14/04/2026	Late Observation	138/97	112	99%	Mild systemic stress
22/04/2026	Discharge	145/104	132	99%	Functional stabilization achieved

These changes paralleled visible improvement in:

Respiratory comfort
Functional tolerance
Daily mobility
Sleep quality
Appetite adaptation
Digestive regulation

From Severe Systemic Instability to Functional Recovery

During the initial phase of treatment, the patient remained in a fragile physiological state characterized by respiratory distress, vomiting, severe weakness, constipation, disturbed sleep, abdominal discomfort, inflammatory stress, and poor functional tolerance.

By the final week of treatment, the patient demonstrated substantial stabilization.

Vomiting resolved completely. Bowel movement normalized. Respiratory discomfort improved significantly. Sleep became more stable, abdominal bloating reduced, and back pain became clinically manageable.

Most importantly, the patient progressed from profound post-chemotherapy instability toward improved functional confidence and enhanced physiological adaptability.

On April 22, 2026, the patient was discharged in clinically stable condition with improved systemic tolerance and better quality-of-life parameters.

What This Case Suggests About Siddha Supportive Oncology Care

This case highlights an important principle emphasized within Siddha medicine: recovery during advanced illness depends not only upon disease-targeted intervention, but also upon restoration of systemic physiological balance.

The improvement in digestive regulation, bowel function, vomiting control, respiratory comfort, sleep adaptability, and functional stability suggests that prognosis-oriented Siddha supportive management may play a meaningful role in integrative oncology care.

Although chemotherapy and surgery remain essential for primary cancer treatment, this case demonstrates how Siddha medicine may contribute during the recovery phase by addressing inflammatory burden, digestive exhaustion, metabolic instability, respiratory discomfort, and Vatha-Pitha imbalance simultaneously.

For patients experiencing prolonged physiological stress after aggressive oncological intervention, whole-body supportive rehabilitation approaches may provide important additional clinical value alongside conventional cancer management.

References

Siddha oncology supportive care literature from the Journal of Ayurveda and Integrative Medicine.
Balachandran P, Govindarajan R. Cancer—An ayurvedic perspective. Journal of Ethnopharmacology.
Ramasamy S. Siddha system and integrative oncology approaches in chronic inflammatory disease management.
Patwardhan B, et al. Ayurveda and traditional systems in supportive cancer care. Journal of Ayurveda and Integrative Medicine.
World Health Organization. Traditional medicine and integrative supportive care frameworks.
Natarajan S, et al. Traditional Siddha therapeutic principles in chronic inflammatory rehabilitation.